Prediction: This Under-the-Radar Artificial Intelligence (AI) Stock Could Be a Multibagger by the End of 2027

DigitalOcean said AI inference ARR rose 254% year over year in Q4 2025, while AI customer ARR increased 150% to $120 million and net dollar retention improved to 101%. Management is projecting 21% revenue growth in 2026, accelerating to more than 25% by late 2026 and 30% in 2027, with revenue potentially reaching $1.5 billion by end-2027. The article argues the stock’s 105% YTD rally could continue if AI demand persists and valuation expands.

Analysis

DOCN is being re-rated less on absolute AI TAM and more on a new proof point: it can monetize inference economics better than the hyperscalers for a narrow but attractive customer set. That matters because startups are the most price-sensitive AI buyers and also the least loyal; if DOCN can lock them in early on lower-latency, lower-cost inference, it creates a path to compounding expansion without needing enterprise-scale share gains. The second-order effect is that this is a margin-and-mix story, not just revenue growth: as AI workloads rise as a share of spend, GPU utilization, networking, and storage attach rates should improve, potentially changing the market’s view of DOCN from a commodity cloud host to a specialized AI edge platform.

The key risk is that the current narrative assumes pricing parity remains stable while demand scales, but hyperscalers can cross-subsidize AI infrastructure to defend strategic accounts. If AWS, Azure, or Google narrow the price/performance gap or bundle inference credits into broader commitments, DOCN’s growth could decelerate sharply over a 6-12 month window even if headline AI demand remains healthy. A second-order downside is customer concentration risk: the more DOCN becomes a “best value” inference venue, the more its growth becomes tied to a cohort of early-stage companies that may be weak financing markets if venture funding tightens.

The market is likely underpricing how much of this move is multiple expansion versus fundamental durability. At this stage, the stock is trading like a clean growth winner, but the real test is whether AI revenue can broaden beyond a few use cases into repeatable workload migration; if not, the multiple can compress quickly once the easy comps roll off. The opportunity is to stay long the inflection but not the full rerating: the setup favors an earnings-driven trade with defined downside rather than a passive long-term hold at peak optimism.

Key Decisions for Investors

• Long DOCN on pullbacks over the next 2-6 weeks; target a 15-20% upside move if management confirms inference mix expansion, but cut if growth guidance fails to inflect beyond the next quarter.
• Pair trade: long DOCN / short a basket of hyperscaler proxies (AMZN, MSFT, GOOGL) for 3-6 months; this isolates pricing-disruption upside while limiting broad AI beta. Risk: hyperscaler cross-subsidy can compress DOCN’s relative performance.
• Buy DOCN call spreads into the next earnings print (3-4 month tenor) to express upside from AI revenue acceleration with defined premium outlay; favorable if the stock is already extended and implied vol remains contained.
• For conservative accounts, avoid outright chase above current multiples; wait for a post-earnings reset or confirmation that AI ARR growth remains above 100% for another quarter before adding size.
• Watch NVDA supply and GPU availability as a catalyst/risk indicator; if inference demand outpaces GPU allocation, DOCN’s growth can be bottlenecked by hardware access rather than customer demand.